Jean-Charles Soria: Precision medicine in oncology is evolving towards high-throughput genomics use.

In a post by Jean-Charles Soria, Senior Vice President of Oncology within Global Development at Amgen, on LinkedIn, says:

“Precision medicine in oncology is evolving towards high-throughput genomics use. This approach may provide vast molecular information in tumors, revealing an average of 4-5 drivers per tumor. Actionable alterations should be prioritized by using validated rankings for treatment tailoring. However, the advent of abundant complex biological data will make artificial intelligence algorithms indispensable for thorough analysis and appropriate treatment decisions.”

For the article click here.
Source: Jean-Charles Soria/LinkedIn